🇺🇸 Ferric Carboxymaltose Injection in United States

17 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain — 2 reports (11.76%)
  2. Blood Pressure Decreased — 2 reports (11.76%)
  3. Fatigue — 2 reports (11.76%)
  4. Haemoglobin Decreased — 2 reports (11.76%)
  5. Hypersensitivity — 2 reports (11.76%)
  6. Nausea — 2 reports (11.76%)
  7. Vomiting — 2 reports (11.76%)
  8. Abortion Infected — 1 report (5.88%)
  9. Alanine Aminotransferase Increased — 1 report (5.88%)
  10. Anaphylactic Reaction — 1 report (5.88%)

Source database →

Other Hematology approved in United States

Frequently asked questions

Is Ferric Carboxymaltose Injection approved in United States?

Ferric Carboxymaltose Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ferric Carboxymaltose Injection in United States?

Sichuan Huiyu Pharmaceutical Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.